(Q34107638)

31 July 2017

1 reference

title

Update on metastatic breast cancer (English)

1 reference

31 July 2017

metastatic breast cancer

1 reference

Perez EA

1

1 reference

31 July 2017

1 September 1999

1 reference

31 July 2017

Current Oncology Reports

1 reference

31 July 2017

1

1 reference

31 July 2017

1

1 reference

31 July 2017

11-15

1 reference

https://scigraph.springernature.com/pub.10.1007/s11912-999-0004-8

31 July 2017

0 references

cites work

A phase II study of paclitaxel plus carboplatin as first-line chemotherapy for women with metastatic breast carcinoma.

1 reference

12 December 2020

Cancer statistics, 1999.

1 reference

12 December 2020

Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. Protocol 18 Aredia Breast Cancer Study Group

1 reference

12 December 2020

The dolastatins, a family of promising antineoplastic agents

1 reference

12 December 2020

5-HT3 antiemetic therapy for patients with breast cancer

1 reference

12 December 2020

Antiangiogenesis for cancer therapy

1 reference

12 December 2020

Phase II trial of liposome-encapsulated doxorubicin, cyclophosphamide, and fluorouracil as first-line therapy in patients with metastatic breast cancer

1 reference

12 December 2020

Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group

1 reference

12 December 2020

Taxanes in the treatment of breast cancer: a prodigy comes of age.

1 reference

12 December 2020

Phase II trial of high-dose liposome-encapsulated doxorubicin with granulocyte colony-stimulating factor in metastatic breast cancer. TLC D-99 Study Group

1 reference

12 December 2020

Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis

1 reference

12 December 2020

HER-2 as a Prognostic, Predictive, and Therapeutic Target in Breast Cancer

1 reference

12 December 2020

Facilitating oligonucleotide delivery: helping antisense deliver on its promise

1 reference

12 December 2020

Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer

1 reference

12 December 2020

Molecular determinants of angiogenesis in cancer metastasis.

1 reference

12 December 2020

Therapeutic intervention and signaling

1 reference

12 December 2020

Pharmacokinetics of antisense oligonucleotides

1 reference

12 December 2020

Paclitaxel plus nonanthracycline combinations in metastatic breast cancer.

1 reference

12 December 2020

10.1007/S11912-999-0004-8

Identifiers

DOI

1 reference

PubMed ID

11122792

Dimensions Publication ID

31 July 2017

0 references

1 reference

PubMed ID

11122792